Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diffuse large B-cell lymphoma (DLBCL)
Pharma
Roche’s bispecific-ADC combo keeps lymphoma at bay
The positive Lunsumio-Polivy readout could give Roche another shot at second-line LBCL as its Columvi contends with a regulatory setback.
Angus Liu
Jun 23, 2025 10:27am
FDA leaders push for more US enrollment in cancer trials
May 20, 2025 12:52pm
J&J, Pfizer and Roche face FDA questions over data applicability
May 16, 2025 3:52pm
Pfizer's blockbuster ADC Adcetris nabs FDA nod in LBCL
Feb 12, 2025 3:06pm
JPM25: Incyte plans to turn 'a lot of cards' in 2025, CEO says
Jan 22, 2025 2:38pm
ASH: Lilly defends survival data blemish in novel BTK trial win
Dec 9, 2024 5:45pm
